Onset of Parkinson’s Disease May Be Slowed by Metabolite in MS Drug, Mouse Study Shows
Dimethylfumarate (Tecfidera), a drug used to harness multiple sclerosis symptoms, generates a metabolite that could be used in Parkinson’s patients to improve defenses against oxidative damage. The drug acts on Nrf2, a molecule that has frequently been suggested as a target for neuroprotective drugs in Parkinson’s, as its activation is a…